Abstract:This chapter aims to give a comprehensive summary of the dual-modality imaging agents that have been reported to date, which are not based on nanoparticles. When compared to other dual-modality agents reported in the literature, dual-modality magnetic resonance imaging (MRI)/optical agents are among the most intensively studied, which can be partly attributed to the wide availability of the imaging agents as well as the imaging systems. Positron emission tomography (PET) imaging has been widely used in clinical oncology for cancer staging and monitoring the therapeutic response to various anticancer therapies. The most common radioisotopes used for single-photon emission computed tomography (SPECT) imaging include 99mTc, 111In, and radioiodine. MRI is a noninvasive diagnostic technique based on the interaction of protons (or other MRI-active nuclei) with each other and with surrounding molecules in a tissue of interest. Different tissues have different relaxation times, which can result in endogenous MRI contrast.

Non-Nanoparticle-Based Dual-Modality Imaging Agents